Luo Rushu
Managing Partner & Co-founder @ Huimei Capital
Luo Rushu is a Series B investor at Huimei Capital focused on Medical and Health Care. Luo Rushu serves as a managing partner at Huimei Capital.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Luo Rushu invests in
Stages Luo Rushu invests in
Countries Luo Rushu invests in
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Series B 1 (33%)
- Series C 1 (33%)
- Series D 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Osteal Therapeutics
|
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $50M / Series D / Jun 05, 2024 | |
|
Osteal Therapeutics
|
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $23M / Series C / Sep 21, 2023 | |
|
Osteal Therapeutics
|
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $30M / Series B / Dec 29, 2021 |
Co-Investors
Johnson & Johnson Development Corporation
3 deals together
Gideon Strategic Partners
1 deal together
GOS Capital
1 deal together
HM Capital
1 deal together
Prism Venture Management
1 deal together
Medvest Capital
1 deal together
About Huimei Capital
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Huimei Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Luo Rushu
Managing Partner & Co-founder
|
|||
Xu Wanning
Partner
|
|||
Song Longtao
Partner & Co-founder
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Luo Rushu invest in?
Luo Rushu invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Luo Rushu last invest?
The most recent investment recorded for Luo Rushu closed in Jun 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
